Clinical Trial Update: Phase I Trial of QH-1A Hybrid Bio-Artificial Liver With Ex Vivo Blood-Purifying MSCs in Acute-on-Chronic Liver Failure [Phase 1]

View source ↗

Summary

Phase I trial of QH-1A Hybrid Bio-Artificial Liver with Ex Vivo Blood-Purifying MSCs for acute-on-chronic liver failure is listed as active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• On Chronic Liver Failure

Drugs mentioned

• QH-1A Hybrid Bio-Artificial Liver With Ex Vivo Blood-Purifying MSCs

Snippet

Sponsor: Third Affiliated Hospital, Sun Yat-Sen University | Conditions: Acute-On-Chronic Liver Failure | Phase 1 | Status: ACTIVE_NOT_RECRUITING